Envista Holdings Corp (NVST)

USD 15.65

(3.16%)

Total Liabilities Summary of Envista Holdings Corp

  • Envista Holdings Corp's latest annual total liabilities in 2023 was 2.43 Billion USD , up 2.15% from previous year.
  • Envista Holdings Corp's latest quarterly total liabilities in 2024 Q3 was 2.43 Billion USD , down -0.94% from previous quarter.
  • Envista Holdings Corp reported annual total liabilities of 2.38 Billion USD in 2022, down -5.41% from previous year.
  • Envista Holdings Corp reported annual total liabilities of 2.51 Billion USD in 2021, down -20.25% from previous year.
  • Envista Holdings Corp reported quarterly total liabilities of 2.46 Billion USD for 2024 Q2, up 1.88% from previous quarter.
  • Envista Holdings Corp reported quarterly total liabilities of 2.41 Billion USD for 2024 Q1, down -0.63% from previous quarter.

Annual Total Liabilities Chart of Envista Holdings Corp (2023 - 2017)

Historical Annual Total Liabilities of Envista Holdings Corp (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 2.43 Billion USD 2.15%
2022 2.38 Billion USD -5.41%
2021 2.51 Billion USD -20.25%
2020 3.15 Billion USD 20.63%
2019 2.61 Billion USD 157.63%
2018 1.01 Billion USD 1.7%
2017 998.2 Million USD 0.0%

Peer Total Liabilities Comparison of Envista Holdings Corp

Name Total Liabilities Total Liabilities Difference
Alcon Inc. 8.98 Billion USD 72.947%
AptarGroup, Inc. 2.13 Billion USD -14.109%
Baxter International Inc. 19.8 Billion USD 87.726%
Becton, Dickinson and Company 26.98 Billion USD 90.99%
Bausch + Lomb Corporation 6.52 Billion USD 62.723%
Haemonetics Corporation 1.23 Billion USD -96.758%
ResMed Inc. 2 Billion USD -21.055%
Teleflex Incorporated 3.09 Billion USD 21.36%
Warby Parker Inc. 278.52 Million USD -772.884%
West Pharmaceutical Services, Inc. 948.5 Million USD -156.321%